Pharmacoresistant epileptic eyelid twitching in a child with a mutation in SYNGAP1

Epileptic Disord. 2017 Sep 1;19(3):339-344. doi: 10.1684/epd.2017.0922.

Abstract

SYNGAP1 gene mutation has been associated with epilepsy which is often drug resistant, with seizure types including eyelid myoclonia. However, detailed descriptions, including ictal video-EEG, have not been reported. We report the case of a 4-year-old boy who developed recurrent epileptic eyelid twitching at 1 year and 5 months of age. Seizures gradually increased in frequency to more than 50 times per day and manifested with upward eye deviation, motion arrest, loss of consciousness, and eyelid twitching lasting for five seconds. Ictal EEG showed rhythmic, generalized slow or spike-and-wave complex activity with posterior predominance. Moderate psychomotor developmental delay and unsteady gait were also noted. Neuroimaging results were normal. Seizures were refractory to carbamazepine and levetiracetam but were reduced in frequency by ethosuximide and lamotrigine administration. Genetic analysis identified a c.3583-6 G>A mutation in the SYNGAP1 gene. SYNGAP1 gene analysis should be considered for intellectually disabled patients with early-onset drug resistant eyelid twitching and photosensitivity. Further clinical research on SYNGAP1 function may be necessary to treat epilepsy of this aetiology. [Published with video sequence on www.epilepticdisorders.com].

Keywords: SYNGAP1; eyelid myoclonia; eyelid twitching; intellectual disability.

Publication types

  • Case Reports

MeSH terms

  • Blepharospasm / diagnosis*
  • Blepharospasm / genetics
  • Blepharospasm / physiopathology
  • Brain / physiopathology*
  • Child, Preschool
  • Drug Resistant Epilepsy / diagnosis*
  • Drug Resistant Epilepsy / genetics
  • Drug Resistant Epilepsy / physiopathology
  • Electroencephalography
  • Humans
  • Male
  • Mutation*
  • ras GTPase-Activating Proteins / genetics*

Substances

  • SYNGAP1 protein, human
  • ras GTPase-Activating Proteins